Dry Eye Disease
Showing 26 - 50 of 149
Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca Trial in Catania (Cross-linked hyaluronic acid eye drops)
Recruiting
- Dry Eye Disease
- +3 more
- Cross-linked hyaluronic acid eye drops
-
Catania, CT, ItalyAzienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023
Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in Catania (Hyaluronic acid eye drops)
Recruiting
- Dry Eye
- +2 more
- Hyaluronic acid eye drops
-
Catania, CT, ItalyAzienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023
Corneal Disease, Neuropathy, Dry Eye Disease Trial (Quantitative Sensory Test)
Not yet recruiting
- Corneal Disease
- +3 more
- Quantitative Sensory Test
- (no location specified)
Feb 24, 2023
Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)
Not yet recruiting
- Dry Eye Disease
- Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023
Dry Eye Disease Trial in France (Idroflog®, Sodium Hyaluronate 0.18% (Vismed®))
Not yet recruiting
- Dry Eye Disease
- Idroflog®
- Sodium Hyaluronate 0.18% (Vismed®)
-
Amiens, France
- +4 more
Feb 2, 2023
Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)
Completed
- Dry Eye Disease
- Reproxalap Ophthalmic Solution (0.25%)
- Placebo Comparator
-
Andover, MassachusettsAndover Eye Associates
Jan 24, 2023
Dry Eye Disease Trial (BRM421 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Dry Eye Disease
- BRM421 Ophthalmic Solution
- Vehicle
- (no location specified)
Jan 13, 2023
Dry Eye Disease Trial in United States (AR-15512 Ophthalmic Solution, Vehicle)
Recruiting
- Dry Eye Disease
- AR-15512 Ophthalmic Solution
- Vehicle
-
Newport Beach, California
- +10 more
Jan 17, 2023
Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)
Completed
- Dry Eye Disease
- CyclASol topical ocular, eye drops
- Vehicle topical ocular, eye drops
-
Newport Beach, California
- +8 more
Dec 21, 2022
Dry Eye Disease Trial in Andover (glycerin 0.7%/PEG 400 0.3%, polyethylene glycol 400 0.4%/propylene glycol 0.3%)
Enrolling by invitation
- Dry Eye Disease
- glycerin 0.7%/PEG 400 0.3%
- polyethylene glycol 400 0.4%/propylene glycol 0.3%
-
Andover, MassachusettsAndover Research Eye Institute
Dec 20, 2022
Dry Eye Disease Trial in Shanghai (Varenicline Tartrate Nasal Spray)
Recruiting
- Dry Eye Disease
- Varenicline Tartrate Nasal Spray
-
Shanghai, ChinaHuashan Hospital
Dec 14, 2022
Dry Eye Disease Trial in United States (AR 15512 Ophthalmic Solution, Vehicle)
Recruiting
- Dry Eye Disease
- AR 15512 Ophthalmic Solution
- Vehicle
-
Torrance, California
- +19 more
Dec 9, 2022
Dry Eye Disease Trial in Memphis (Naltrexone, Placebos)
Ocular Surface of Visual Display Users With and Without Dry Eye
Completed
- Dry Eye Disease
- no intervention
-
Beijing, ChinaPeking University Third Hospital
Nov 20, 2022
Dry Eye Disease Trial in United States (0.02% Betamethasone Sodium Phosphate, 0.04% Betamethasone Sodium Phosphate, Placebo)
Completed
- Dry Eye Disease
- 0.02% Betamethasone Sodium Phosphate
- +2 more
-
Dothan, Alabama
- +27 more
Nov 9, 2022
Dry Eye Disease Trial in United States (A197 Ophthalmic Solution, A197 Vehicle Control, Active Comparator)
Active, not recruiting
- Dry Eye Disease
- A197 Ophthalmic Solution
- +2 more
-
Birmingham, Alabama
- +23 more
Nov 8, 2022
Dry Eye Disease Trial (IPRL device, pharmacological therapy & Eyelid hygiene)
Not yet recruiting
- Dry Eye Disease
- IPRL device
- pharmacological therapy & Eyelid hygiene
- (no location specified)
Oct 30, 2022